GlassScriptPhysician profile
Camille Stevenson
NPI 1659522472
$2,354.31
in general payments reported to CMS, 2019-2025
20 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.95 · 2020: $112 · 2021: $177 · 2022: $148 · 2023: $215 · 2024: $220 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,018 · Food and Beverage: $743 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,017.78 |
| Food and Beverage | $742.73 |
| Education | $107.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,123.28 | 2025 | |
| Abbvie INC. | $290.67 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $260.93 | 2023-2025 | Veozah, Myrbetriq |
| Organon LLC | $84.57 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $77.65 | 2020-2023 | Injectafer |
| Pfizer INC. | $56.34 | 2022-2023 | |
| Exeltis, USA INC. | $55.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.59 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $49.27 | 2025 | Gemtesa |
| Innovation Technologies INC | $44.46 | 2025 | Irrisept |
| Shield Therapeutics INC | $42.77 | 2024-2025 | |
| Coopersurgical, INC. | $35.56 | 2019-2024 | Paragard T 380a |
| Biogen, INC. | $34.47 | 2025 | Zurzuvae |
| Baxter Healthcare | $30.98 | 2025 | Seprafilm |
| Hologic Sales and Service, LLC | $28.70 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $26.87 | 2025 | Prevena |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Mayne Pharma Commercial LLC | $14.53 | 2025 | |
| Axonics, INC. | $13.44 | 2021 | |
| Agile Therapeutics, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camille Stevenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.